Bausch Health Companies | Należności Handlowe



Trade Debtors Zmiana Data
Amgen USD 6.78B 535M 2024-12
ANI Pharmaceuticals USD 221.73M 19.26M 2024-12
Aurora Cannabis CAD 49.52M 9.36M 2024-12
Bausch Health Companies USD 2.09B 8M 2024-09
Biogen USD 1.87B 119.3M 2024-12
Bristol-Myers Squibb USD 14.42B 471M 2024-12
Canopy Growth CAD 49.06M 7.2M 2024-12
Corcept Therapeutics USD 53.98M 5.74M 2024-12
Danaher USD 3.54B 560M 2024-12
Drreddys Laboratories INR 111.49B 8.65B 2024-12
Eli Lilly USD 13.28B 1.22B 2024-12
Gilead Sciences USD 4.42B 167M 2024-12
Novo Nordisk 79.63B 3.5B 2024-09
Pacira USD 113.3M 12.65M 2024-12
Perrigo USD 686.2M 99.7M 2024-12
Prestige Brands USD 167.27M 3.73M 2024-12
Supernus Pharmaceuticals USD 142.08M 3.33M 2024-12
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12
Zoetis USD 1.32B 95M 2024-12



Bausch Health Companies Należności Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.